VIM is nearly always expressed in mesenchymal tissues and has been reported to have good performance for prognostic prediction of CRC.17,18 Therefore, we initiated a systematic search for markers that can suppress the expression of mesenchymal VIM, which may be able to suppress the activation of CAFs in CRC. This evidence concerns the gene TBX1 and colorectal carcinoma.